微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.88% | 319.05% | 117.92% | 75/131 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -4.91% | -165.03% | -1082% | 110/131 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 0.5% | -94.85% | 363.16% | 102/131 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -0.19% | -102.19% | -190.48% | 106/131 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.21% | -97.51% | -97.22% | 98/131 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 7.55% | -2.83% | -22.25% | 51/131 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 9.71% | 3.3% | 12.12% | 28/131 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 8.66% | 41.97% | 2.49% | 12/131 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 8.45% | 113.92% | 8.75% | 2/131 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 7.77% | -61.8% | -17.34% | 73/131 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 9.4% | -45.57% | 54.1% | 57/131 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 6.1% | -49.04% | 54.43% | 63/131 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 3.95% | -44.05% | -80.58% | 38/131 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 20.34% | -66.42% | 17.78% | 38/131 | 17.4% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 17.27% | -70.42% | 44.28% | 35/131 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 11.97% | -74.65% | 69.55% | 39/131 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 7.06% | -30.51% | -88.35% | 22/131 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 60.58% | 351.42% | 3.75% | 14/131 | 25.69% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 58.39% | 153.98% | 23.68% | 8/131 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 47.21% | 877.43% | 251.79% | 11/131 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2019-12-31 | 13.42% | 9.37% | 9.37% | 59/131 | 14.38% | 圣湘生物 | 29.33% | 行业排名> |
| 2018-12-31 | 12.27% | -27.74% | 154.04% | 59/131 | 12.98% | 健尔康 | 84.09% | 行业排名> |
| 2018-06-30 | 4.83% | -68.41% | -71.55% | 27/131 | 3.21% | 祥生医疗 | 28.56% | 行业排名> |
| 2017-12-31 | 16.98% | -39.36% | 67.13% | 40/131 | 13.82% | 心脉医疗 | 31.04% | 行业排名> |
| 2017-03-31 | 10.16% | 2% | -63.71% | 2/131 | 2.66% | 新华医疗 | 13.55% | 行业排名> |
| 2016-12-31 | 28% | 14.33% | 21.79% | 15/131 | 16.21% | 安旭生物 | 48.71% | 行业排名> |
| 2016-09-30 | 22.99% | 2% | 50.36% | 3/131 | 8.69% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2016-06-30 | 15.29% | 2% | -37.57% | 5/131 | 6.26% | 明德生物 | 14.54% | 行业排名> |
| 2015-12-31 | 24.49% | 4.3% | 4.3% | 12/131 | 15.95% | 迈瑞医疗 | 11% | 行业排名> |